BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 19458304)

  • 1. Treatment of peritoneal dialysis-related peritonitis with ciprofloxacin monotherapy: clinical outcomes and bacterial susceptibility over two decades.
    Fontán MP; Cambre HD; Rodríguez-Carmona A; Muñiz AL; Falcón TG
    Perit Dial Int; 2009; 29(3):310-8. PubMed ID: 19458304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of CAPD-related peritonitis with ciprofloxacin: results after seven years.
    Bouza P; García Falcón T; Pérez Fontán M; Rodríguez-Carmona A; López Vázquez M; Tresancos C; Valdés F
    Adv Perit Dial; 1996; 12():185-8. PubMed ID: 8865898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peritonitis remains the major clinical complication of peritoneal dialysis: the London, UK, peritonitis audit 2002-2003.
    Davenport A
    Perit Dial Int; 2009; 29(3):297-302. PubMed ID: 19458302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The need for a center-tailored treatment protocol for peritonitis.
    Van Biesen W; Vanholder R; Vogelaers D; Peleman R; Verschraegen G; Vijt D; Lameire N
    Perit Dial Int; 1998; 18(3):274-81. PubMed ID: 9663891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vancomycin and ciprofloxacin: systemic antibiotic administration for peritoneal dialysis-associated peritonitis.
    Goffin E; Herbiet L; Pouthier D; Pochet JM; Lafontaine JJ; Christophe JL; Gigi J; Vandercam B
    Perit Dial Int; 2004; 24(5):433-9. PubMed ID: 15490982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 32 years' experience of peritoneal dialysis-related peritonitis in a university hospital.
    van Esch S; Krediet RT; Struijk DG
    Perit Dial Int; 2014; 34(2):162-70. PubMed ID: 24584620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbiological Trends and Antimicrobial Resistance in Peritoneal Dialysis-Related Peritonitis, 2005 to 2014.
    Zelenitsky SA; Howarth J; Lagacé-Wiens P; Sathianathan C; Ariano R; Davis C; Verrelli M
    Perit Dial Int; 2017; 37(2):170-176. PubMed ID: 27738087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of outcome following bacterial peritonitis in peritoneal dialysis.
    Krishnan M; Thodis E; Ikonomopoulos D; Vidgen E; Chu M; Bargman JM; Vas SI; Oreopoulos DG
    Perit Dial Int; 2002; 22(5):573-81. PubMed ID: 12455568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four-year analysis of microbial aetiology and antimicrobial sensitivity patterns of peritoneal-dialysis related peritonitis in a tertiary care facility.
    Persy B; Ieven M
    Acta Clin Belg; 2013; 68(1):48-53. PubMed ID: 23627195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viridans streptococcus peritonitis in peritoneal dialysis: clinical characteristics and comparison with concurrent polymicrobial infection.
    Liu Y; Cheng BC; Liu JW; Chen CJ; Kuo LC; Chang WX; Chen JB
    BMC Nephrol; 2018 Oct; 19(1):271. PubMed ID: 30340562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors for and Outcomes of Catheter-Associated Peritonitis in Children: The SCOPE Collaborative.
    Sethna CB; Bryant K; Munshi R; Warady BA; Richardson T; Lawlor J; Newland JG; Neu A;
    Clin J Am Soc Nephrol; 2016 Sep; 11(9):1590-1596. PubMed ID: 27340282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The changing profile of PD-related peritonitis in Thailand: a single centers experience.
    Pattanachaiwit N; Gojaseni P; Junrak J; Riengchan P; Pajareya T; Chittinandana A
    J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S44-51. PubMed ID: 22043566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbiology and outcomes of peritonitis in Australian peritoneal dialysis patients.
    Ghali JR; Bannister KM; Brown FG; Rosman JB; Wiggins KJ; Johnson DW; McDonald SP
    Perit Dial Int; 2011; 31(6):651-62. PubMed ID: 21719685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Center Effects and Peritoneal Dialysis Peritonitis Outcomes: Analysis of a National Registry.
    Htay H; Cho Y; Pascoe EM; Darssan D; Nadeau-Fredette AC; Hawley C; Clayton PA; Borlace M; Badve SV; Sud K; Boudville N; McDonald SP; Johnson DW
    Am J Kidney Dis; 2018 Jun; 71(6):814-821. PubMed ID: 29289475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ciprofloxacin and cefazolin as a combination for empirical initial therapy of peritoneal dialysis-related peritonitis: five-year follow-up.
    Lima RC; Barreira A; Cardoso FL; Lima MH; Leite M
    Perit Dial Int; 2007; 27(1):56-60. PubMed ID: 17179512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathogen spectrum and resistance in patients with peritoneal dialysis-associated peritonitis: A single-center, observational clinical study
.
    Yang L; Gong N; Zhou H; Jiang J
    Clin Nephrol; 2019 Jul; 92(1):44-51. PubMed ID: 31131821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymicrobial peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes.
    Barraclough K; Hawley CM; McDonald SP; Brown FG; Rosman JB; Wiggins KJ; Bannister KM; Johnson DW
    Am J Kidney Dis; 2010 Jan; 55(1):121-31. PubMed ID: 19932543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritonitis-related mortality in patients undergoing chronic peritoneal dialysis.
    Pérez Fontan M; Rodríguez-Carmona A; García-Naveiro R; Rosales M; Villaverde P; Valdés F
    Perit Dial Int; 2005; 25(3):274-84. PubMed ID: 15981776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and microbiological characteristics of peritoneal dialysis-related peritonitis caused by Escherichia coli in southern Taiwan.
    Lin WH; Tseng CC; Wu AB; Chang YT; Kuo TH; Chao JY; Wang MC; Wu JJ
    Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1699-1707. PubMed ID: 29931659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing
    Chen HC; Shieh CC; Sung JM
    Perit Dial Int; 2018; 38(4):266-270. PubMed ID: 29987065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.